Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/16/03 → 7/31/05 |
A Multi-Center, Randomized, Double-blind, Placebo-Controlled Phase 2a Dose-Response Study of the Safety, and Tolerability, of two does of RO3300074 Given for 4 weeks to Patients with Moderate to Sever Syptomatic Emphysema
- Doherty, Dennis (PI)
- Buch, Ketan (CoI)